Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials-Reference-Cited by-同舟云学术

Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials

Published:2022-04-29 Issue:7 Volume:97 Page:885-894
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Kim Kunhwa¹^ORCID,Konopleva Marina¹^ORCID,DiNardo Courtney D.¹^ORCID,Borthakur Gautam¹^ORCID,Loghavi Sanam²^ORCID,Tang Guilin²^ORCID,Daver Naval¹^ORCID,Pemmaraju Naveen¹^ORCID,Jabbour Elias¹^ORCID,Rausch Caitlin R.¹^ORCID,Yilmaz Musa¹^ORCID,Sasaki Koji¹^ORCID,Short Nicholas J.¹^ORCID,Jain Nitin¹,Brandt Mark¹,Pierce Sherry¹,Garcia‐Manero Guillermo¹^ORCID,Ravandi Farhad¹^ORCID,Kantarjian Hagop¹,Kadia Tapan M.¹^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26572

Reference27 articles.

1. How I treat hyperleukocytosis in acute myeloid leukemia

2. Early ICU Admission Of Newly Diagnosed Acute Myeloid Leukemia With No Organ Failure